In sporadic CRC, it was shown that the B. fragilis ETBF strain produces the toxin fragylisin, a metalloproteinase increased in patients with advanced CRC that is responsible for increasing mucosal permeability, enhancing IL-17 cytokine secretion and STAT3 activation [52]. The gene discussed is IL17A; the disease is colorectal carcinoma.